Joe Biden Diagnosed with Prostate Cancer, Raising Awareness on the Disease

Former American President Joe Biden, who left office in January, has been diagnosed with prostate cancer. The diagnosis comes after he dropped out of the 2024 US presidential race due to health concerns. Biden's office has confirmed that the cancer has spread to his bones and has been classified as "high-grade." This news has sparked a renewed interest in understanding prostate cancer, its causes, and prevention methods.

Key Takeaways:

• Prostate cancer is the second most common form of cancer among men, after skin cancer, with 13 out of every 100 men developing the disease at some point in their lives (US Centres for Disease Control and Prevention).
• Prostate cancer occurs when cells in the prostate gland grow out of control, and its exact cause is still unknown, but factors such as old age, obesity, tobacco smoking, and having a family history of the disease can increase the risk.
• Early-stage prostate cancer has a good survival rate, with most patients living for several years, and even in advanced stages, patients can expect to live for years with proper treatment.
• Prostate cancer may not present symptoms initially, but common symptoms include blood in the urine, blood in the semen, frequent urination, and difficulty urinating.
• Advanced prostate cancer can cause symptoms such as accidental urine leakage, back pain, bone pain, feeling exhaustion, loss of weight, and weakness in limbs.
• The cancer has been classified as "high-grade" and has spread to Joe Biden's bones.

Statistics:

• 13 out of every 100 men will develop prostate cancer at some point in their lives (US Centres for Disease Control and Prevention).
• Prostate cancer is the second most common form of cancer among men, after skin cancer.
• Early-stage prostate cancer has a good survival rate, but advanced stages can have a manageable survival rate with proper treatment.

Sources:

• US Centres for Disease Control and Prevention
• Cleveland Clinic
• Diligent Media Corporation Ltd., DNA (Daily News & Analysis)